Clinical trial

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

NCT00531804

Study summary

ClinicalTrials.gov

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention gantenerumab Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-12-01

PhasePHASE1

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Interventions

gantenerumabDRUG

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

AmsterdamNetherlands1 StockholmSweden1 CopenhagenDenmark1 GlasgowUnited Kingdom1 Ramat GanIsrael1 MalmöSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00531804 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.